EARLY ON-TREATMENT HBSAG AND HBV DNA LEVELS IDENTIFY HBEAG-NEGATIVE PATIENTS NOT RESPONDING TO 48 OR 96 WEEKS OF PEGINTERFERON ALFA-2A THERAPY
Author
Lampertico, Pietro
Colombo, Massimo
Janssen, Harry L.
Tabak, Fehmi
Cakaloglu, Yilmaz
Rijckborst, Vincent
Hansen, Bettina E.
Ferenci, Peter
Brunetto, Maurizio R.
Lanza, Alfonso G.
Messina, Vincenzo
Iannacone, Claudio
Massetto, Benedetto
Martins, Eduardo B.
Metadata
Show full item recordCollections
- Bildiri [64839]